Breakthrough Hepatitis B Virus Infection in a Liver Transplant Recipient on Lamivudine Prophylaxis for Donor Hepatitis B Core Antibody Seropositivity: A Review of Practices to Prevent De Novo Hepatitis B Virus Infection After Transplant

Authors :: Edie L. Chan
Eric Bhaimia
Nikunj Shah
Carlos A. Q. Santos
Jae Hyung Jung
Source :: Clin Liver Dis (Hoboken)
Publication Year :: 2021
Publisher :: John Wiley and Sons Inc., 2021.

Subjects :: Hepatitis B virus
Hepatology
business.industry
Lamivudine
Reviews
medicine.disease_cause
Virology
Hepatitis b core antibody
Virus
Liver transplant recipient
medicine
Breakthrough hepatitis
business
medicine.drug

Tools